Irisin attenuates lipopolysaccharide-induced acute lung injury by downregulating inflammatory cytokine expression through miR-199a-mediated Rad23b overexpression
Highlights: • Acute lung injury (ALI) is a leading cause of mortality and therapies for ALI are yet to be thoroughly investigated. • Recent evidence has shown that irisin attenuates lipopolysaccharide-induced acute lung injury. • Irisin can alleviate ALI by inhibiting miR-199a and upregulating Rad23b expression. Acute lung injury (ALI) is a leading cause of mortality as a result of inflammatory cytokine overexpression and increased rates of apoptosis. Therapies for ALI are yet to be thoroughly investigated. Recent evidence has shown that irisin exerts protective effects against many types of pathologies. The present study aimed to determine the function of irisin in an ALI mouse model induced by lipopolysaccharide (LPS) and the corresponding underlying mechanisms at the tissue, cellular, and molecular levels.